[Federal Register Volume 85, Number 18 (Tuesday, January 28, 2020)]
[Notices]
[Pages 4991-4992]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01380]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-20-1158]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled, ``CDC Ideation Catalyst (I-Catalyst) Program 
and Customer Engagement Information Collection'' to the Office of 
Management and Budget (OMB) for review and approval. CDC previously 
published a ``Proposed Data Collection Submitted for Public Comment and 
Recommendations'' notice on October 25, 2019 to obtain comments from 
the public and affected agencies. CDC received one comment. This notice 
serves to allow an additional 30 days for public and affected agency 
comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

    CDC Ideation Catalyst (I-Catalyst) Program and Customer Engagement 
Information Collection (OMB Control No. 0920-1158, Exp. 1/31/2020)--
Revision--Office of Science, Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    The CDC Office of Technology and Innovation (OTI), located within 
CDC's Office of Science (OS), fosters innovative science and promotes 
the testing and implementation of innovative ideas that improve CDC's 
ability to have public health impact. To arm CDC staff with an expanded 
skill-set and tools to evaluate and translate their insights and ideas 
into solutions, CDC developed an experiential innovation curriculum and 
consultation service called Ideation Catalyst (I-Catalyst). The program 
was created with the belief that innovation should be customer-driven, 
based on user research, and enhanced by the engagement of people at all 
levels of an organization. CDC also obtained OMB approval for a generic 
clearance to support the collection of information from stakeholders 
and customers, utilizing I-Catalyst program principles and methodology 
(CDC I-Catalyst Program, OMB No. 0920-1158, exp. date 1/31/2020).
    The goal of the I-Catalyst program and service is to help CDC 
explore, develop, and test new approaches to solving public health 
problems through a discovery, ideation, and prototyping process. I-
Catalyst offers a process for defining problems and engaging 
stakeholders that improves the quality, efficiency, and performance of 
innovative solutions. Through the I-Catalyst process, teams of CDC 
program representatives, in consultation with OTI, work with 
stakeholders to define and articulate a problem and to identify 
potentially effective solutions. Participating teams go through a 
hypothesis-testing, scientific method of discovery to gather important 
insights and identify technical or contextual issues associated with 
defining a problem or implementing a solution. Teams are forced ``out 
of the classroom'' to conduct interviews, study customer/stakeholder 
needs, collect feedback, and find partnership opportunities. Only 
conversations with potential customers/stakeholders can provide the 
facts from which hypotheses are proven or disproven about whether a 
solution (i.e., a product, process, etc.) creates value for the 
intended customer/stakeholder.
    CDC estimates that an average of 10-20 project teams will 
participate in the I-Catalyst process per year. On average, each team 
will collect information from approximately 25 customers/stakeholders 
(a total of 500 respondents per year). Information will be collected 
primarily through on-site, unstructured interviews with individuals who 
represent the customers or stakeholders CDC teams are attempting to 
serve or benefit. CDC may also collect

[[Page 4992]]

information through telephone interviews, questionnaires, or web-based 
surveys. The estimated average burden per response may vary from 20-60 
minutes, with an average of 30 minutes. Information to be collected 
includes respondents' perspectives regarding needs, values, and 
barriers relevant to developing potential solutions.
    CDC expects that teams participating in the I-Catalyst process and 
OTI consultations will be empowered to implement innovative strategies 
and solutions that create value for their stakeholders. The ultimate 
goal is to provide CDC staff with real-world, hands-on training and the 
skills needed to create value-based solutions that benefit society and 
broaden the agency's impact.
    In this Revision request, CDC seeks approval for minor changes to 
the I-Catalyst generic clearance. (1) The total number of respondents 
and burden hours will decrease based on participation in the I-Catalyst 
process during the period 2017-2019. Project-specific estimates will be 
included with each submission under the I-Catalyst generic clearance. 
(2) CDC/ATSDR programs may request OTI approval to use the I-Catalyst 
generic if (a) program representatives completed relevant OTI training 
in 2017-2019, (b) program representatives participate in relevant OTI 
training or mentored technical assistance in 2020-2022, or (c) OTI 
determines that project goals and methodology are consistent with the 
I-Catalyst process. These changes will allow OTI to make the OMB 
approval process easier for a broader pool of qualified customer 
discovery projects. (3) The title of the clearance is being updated to 
reflect its use by additional CDC/ATSDR project teams approved by OTI.
    The I-Catalyst clearance will continue to be used for information 
collections necessary to explore the needs and preferences of specific 
stakeholder groups, and to improve the impact of CDC products, 
programs, and technologies. All projects submitted to OMB for approval 
under the I-Catalyst generic clearance will be consistent with CDC/OTI 
goals for promoting scientific innovation and customer engagement in 
public health.
    OMB approval is requested for three years. Participation is 
voluntary and there are no costs to respondents other than their time. 
The total estimated annualized burden hours are 250.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                   Number of     Average  burden
         Type of respondents                 Form name            Number of      responses  per   per  response
                                                                 respondents       respondent       (in hours)
----------------------------------------------------------------------------------------------------------------
External Partners, Stakeholders, or   Interview Guides,                   500                1            30/60
 Customers.                            Questionnaires, and
                                       Surveys.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2020-01380 Filed 1-27-20; 8:45 am]
 BILLING CODE 4163-18-P